Pharmacotherapy for patients with obesity
KM Gadde, JW Apolzan, HR Berthoud - Clinical chemistry, 2018 - academic.oup.com
BACKGROUND Although pharmacotherapy is not the cornerstone of obesity treatment, it is
a valuable tool that could be considered for patients who have not had adequate benefit …
a valuable tool that could be considered for patients who have not had adequate benefit …
[HTML][HTML] Pharmacotherapy for Patients with Obesity
KM Gadde, JW Apolzan, HR Berthoud - Clinical chemistry, 2018 - ncbi.nlm.nih.gov
BACKGROUND: Although pharmacotherapy is not the cornerstone of obesity treatment, it is
a valuable tool that could be considered for patients who have not had adequate benefit …
a valuable tool that could be considered for patients who have not had adequate benefit …
Pharmacotherapy for Patients with Obesity
KM Gadde, JW Apolzan, HR Berthoud - Clinical Chemistry, 2018 - search.proquest.com
Although pharmacotherapy is not the cornerstone of obesity treatment, it is a valuable tool
that could be considered for patients who have not had adequate benefit from lifestyle …
that could be considered for patients who have not had adequate benefit from lifestyle …
Pharmacotherapy for Patients with Obesity
KM Gadde, JW Apolzan, HR Berthoud - Clinical chemistry, 2018 - pubmed.ncbi.nlm.nih.gov
Background Although pharmacotherapy is not the cornerstone of obesity treatment, it is a
valuable tool that could be considered for patients who have not had adequate benefit from …
valuable tool that could be considered for patients who have not had adequate benefit from …
Pharmacotherapy for patients with obesity.
KM Gadde, JW Apolzan, HR Berthoud - 2018 - cabidigitallibrary.org
BACKGROUND: Although pharmacotherapy is not the cornerstone of obesity treatment, it is
a valuable tool that could be considered for patients who have not had adequate benefit …
a valuable tool that could be considered for patients who have not had adequate benefit …
[PDF][PDF] Pharmacotherapy for Patients with Obesity
KM Gadde, JW Apolzan, HR Berthoud - Clinical Chemistry, 2018 - academia.edu
BACKGROUND: Although pharmacotherapy is not the cornerstone of obesity treatment, it is
a valuable tool that could be considered for patients who have not had adequate benefit …
a valuable tool that could be considered for patients who have not had adequate benefit …
Pharmacotherapy for Patients with Obesity.
KM Gadde, JW Apolzan, HR Berthoud - Clinical Chemistry, 2017 - europepmc.org
BACKGROUND: Although pharmacotherapy is not the cornerstone of obesity treatment, it is
a valuable tool that could be considered for patients who have not had adequate benefit …
a valuable tool that could be considered for patients who have not had adequate benefit …
[引用][C] Pharmacotherapy for Patients with Obesity
KM Gadde, JW Apolzan, HR Berthoud - Clinical Chemistry, 2018 - go.gale.com